28 years old
http://www.cureasps.org/forum/viewtopic.php?f=4&t=956
His tumor in his leg is within 5 to 10 mm of similar dimensions of his shoulder tumor.
He has to date had a good response to votrient. A very promising blood/bone/ brain barrier drugSome of you asked about the sizes. The current sizes of tumors: soft part of right thigh (primary) - 68x36x46 mm, left scapula - 63x37x56, right flank-bone - 40x27x38 mm, dozens of metastases in lungs - 2-14 mm each, Th4 - 25x15 mm. My tumors are encapsulated, they are not visible as a lump.
Olga please correct me if I am wrong
Wouldn't it be wonderful if votrient was the controller of this because the shoulder is the culprit not the soft tissue of the thigh
WE are hoping the response from votrient last forever
From the article
Published online Jul 6, 2013.
Only 2 previous reports of ASPS in the scapular region have been previously reported in the medical literature [9, 10]. Radiologic findings reported in these cases were similar to ours: ill-defined osteolytic lesions were observed on plain radiographs, and an expansile bone tumor with large intra- and extraosseous soft tissue masses was observed on CT as well as moderately high signal intensity with foci of signal void corresponding to dilated blood vessels on T1- and T2-weighted MR images. The case presented is the third such case and includes extensive radiologic and scintigraphic findings. In conclusion, ASPS should be taken into consideration in the differential diagnosis of bone-originating highly vascularized soft tissue masses; characteristic features of the lesion (high-flow vascular structures and aggressive solid component) contribute to differentiating this entity from other hypervascular bone tumors such as rhabdomyosarcoma, hemangioendothelioma and hemangiopericytoma. The primary therapeutic approach consists of surgical exploration in combination with radiotherapy treatment.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724132/